Comutagenicity, competitive enzyme substrates, and in vitro carcinogenicity assays.
D000818:Animals; D001391:Azo Compounds / Q000494:pharmacology; D001711:Biotransformation; D002273:Carcinogens / Q000494:pharmacology*; D002460:Cell Line; D002470:Cell Survival; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D005821:Genetic Techniques; D008099:Liver / Q000378:metabolism; D009153:Mutagens; D051381:Rats; D004124:p-Dimethylaminoazobenzene / Q000378:metabolism*
D001391:Azo Compounds; D002273:Carcinogens; D009153:Mutagens; D004124:p-Dimethylaminoazobenzene